Ovid Therapeutics Inc.
OVID
$0.3383
-$0.0117-3.34%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 49.50% | 33.02% | 39.58% | 1.44% | 3.38% |
| Total Depreciation and Amortization | 7.92% | -31.68% | -49.89% | -61.53% | -58.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -932.02% | -610.02% | -584.64% | -116.71% | -37.77% |
| Change in Net Operating Assets | -106.29% | 426.59% | 264.35% | 121.87% | 128.99% |
| Cash from Operations | -22.23% | -34.41% | -15.84% | -6.57% | 17.10% |
| Capital Expenditure | -77.50% | 57.79% | 54.86% | 96.23% | 96.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2,251.32% | -136.15% | -144.66% | 77.29% | 97.07% |
| Cash from Investing | 2,215.23% | -136.43% | -144.98% | 77.69% | 97.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 16.26% | 30.48% | 133.87% | 169.66% | 138.63% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -97.96% | 6,587.39% | 9,659.81% | 14,210.49% | 16,807.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -100.00% | -100.00% | -- | 400.00% | -- |
| Net Change in Cash | 95.85% | -5,067.88% | -3,426.62% | 68.85% | 87.53% |